Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Nassiri

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 20, 2019
Recurrent KRAS mutations in papillary renal neoplasm with reverse polarityKhaleel I Al-Obaidy, John N Eble, Mehdi Nassiri, et al.
The Journal of Molecular Diagnostics : JMD|October 17, 2021
Electronic Health Records and Genomics: Perspectives from the Association for Molecular Pathology Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working GroupAlexis B Carter, Lynne V Abruzzo, Julie W Hirschhorn, et al.
Oncotarget|February 22, 2018
Consecutive epigenetically-active agent combinations act in <i>ID1-RUNX3-TET2</i> and <i>HOXA</i> pathways for <i>Flt3ITD+ve</i> AMLHamid Sayar, Yan Liu, Rui Gao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2021
EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinomaKhaleel I Al-Obaidy, Julia A Bridge, Liang Cheng, et al.
Oncotarget|July 23, 2016
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancersMilan Radovich, Patrick J Kiel, Stacy M Nance, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2022
Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarityKhaleel I Al-Obaidy, Rola M Saleeb, Kiril Trpkov, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 20, 2019
Recurrent KRAS mutations in papillary renal neoplasm with reverse polarityKhaleel I Al-Obaidy, John N Eble, Mehdi Nassiri, et al.
The Journal of Molecular Diagnostics : JMD|October 17, 2021
Electronic Health Records and Genomics: Perspectives from the Association for Molecular Pathology Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working GroupAlexis B Carter, Lynne V Abruzzo, Julie W Hirschhorn, et al.
Oncotarget|February 22, 2018
Consecutive epigenetically-active agent combinations act in <i>ID1-RUNX3-TET2</i> and <i>HOXA</i> pathways for <i>Flt3ITD+ve</i> AMLHamid Sayar, Yan Liu, Rui Gao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2021
EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinomaKhaleel I Al-Obaidy, Julia A Bridge, Liang Cheng, et al.
Oncotarget|July 23, 2016
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancersMilan Radovich, Patrick J Kiel, Stacy M Nance, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2022
Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarityKhaleel I Al-Obaidy, Rola M Saleeb, Kiril Trpkov, et al.
Pageof 5